Related Experiment Video
Updated: Jun 26, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Clonal expansion of different mtDNA variants without selective advantage in solid tumors
Julia Gekeler1, Gábor Zsurka, Wolfram S Kunz
1Institute of Vegetative Physiology, Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, University of Köln, Germany.
Researchers investigated mitochondrial DNA (mtDNA) mutations in head and neck cancer. They found tumors can eliminate existing mtDNA alleles, suggesting mutations accumulate via random expansion, not necessarily for tumor growth.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Head and neck squamous cell carcinoma (HNSCC) is a significant global health concern.
- Mitochondrial DNA (mtDNA) mutations are frequently observed in various cancers, but their role in tumor development remains debated.
- The Warburg effect, a hallmark of cancer metabolism, is often linked to mtDNA alterations.
Purpose of the Study:
- To investigate tumor-specific mitochondrial DNA (mtDNA) mutations in head and neck squamous cell cancer.
- To determine the mechanism of mtDNA mutation accumulation in solid tumors.
- To assess whether mtDNA mutations are essential for the Warburg effect.
Main Methods:
- Analysis of mitochondrial DNA (mtDNA) heteroplasmy in blood and tumor tissues from patients with head and neck squamous cell cancer.
- Whole mtDNA sequencing (16.5 kb) to identify specific mutations and allele frequencies.
- Comparison of mtDNA genotypes between paired tumor and blood samples.
Main Results:
- Two individuals with head and neck squamous cell cancer exhibited mtDNA heteroplasmy in their blood.
- Tumor tissues in both cases were homoplasmic, containing only one of the two mtDNA alleles found in the blood.
- In one case, the tumor selected the wild-type allele, while in the other, it exclusively retained the mutant allele.
- The identified heteroplasmic sites in the D-loop region were the sole differences between tumor and blood mtDNA.
Conclusions:
- Tumor-specific mtDNA mutations in HNSCC appear to arise from clonal expansion of pre-existing alleles.
- The selection of specific mtDNA alleles (wild-type or mutant) in tumors suggests a random or stochastic process.
- mtDNA mutations are not a prerequisite for the metabolic alterations characteristic of cancer, such as the Warburg effect.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

